Top 5 InsurTech Angel Investors in Isle of Man (July 2026)

Portfolio highlights

• Bourn — Bourn's technology is designed to automate cash flow management, offering SMEs fast access to capital.
• Alfa AI — Alfa AI is a recruitment technology company specializing in AI-driven hiring solutions.
• Emblematic — The first AI-driven Agentic Automation platform, designed to fully automate and enhance the accuracy of Finance Operations, including Bookkeeping, IFRS/GAAP Compliance, Reconciliations, and more.

Portfolio highlights

• Cargofy — Cargofy it's a mobile assistant, kind of a "Siri" but for truck drivers. We help truckers access to high paying loads through our app, and receive discounts on fuel, maintenance, and truck parts.
• seedata.io — Seedata.io's automated deception platform plants, maintains and monitors honeypot traps throughout your estate, catching attackers before damage is done.
• MONET — Embedded finance for agencies and B2B platforms. Frictionless access to white-labelling B2B credit, global payments and new revenue streams. Offer white-label invoice finance to your network, driving growth for you and your suppliers.

Portfolio highlights

• Dognosis — Dognosis is a deeptech startup based in Bangalore building olfaction AI to unlock disease screening at scale. We work with wearable brain-computer interfaces (BCIs), sensor fusion, machine learning, and highly trained biomedical detection dogs to understand scent in unprecedented ways. We are currently focused on developing a breath-basedpan-cancer screening test that will be ultra-affordable, low-friction, and extremely cost-effective. Dognosis is lead by Akash Kulgod, a UC Berkeley trained cognitive scientist and Itamar Bitan, a former IDF K9 professional, and currently consists of 16 full-time employees in engineering, computational neuroscience, and clinical operations.
• Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
• VIAN Therapeutics — VIAN Therapeutics is an early-stage biotechnology company focused on transforming retinal disease treatment. With a first-in-class, non-invasive eyedrop as its lead product, VIAN aims to replace invasive injections for conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME). Backed by strong preclinical data andongoing clinical testing, VIAN is positioned to address significant unmet medical needs and disrupt the $15 billion retinal disease market.

Portfolio highlights

• Ascendx Cloud — Supercharge Salesforce with connected apps that streamline sales, automate data, and drive enterprise-scale growth - Salesforce Solutions By Ascendx
• Firenze — Firenze aims to expand financial services by extending investment-backed lending to a wider audience, recognizing its importance in wealth creation and preservation. The founding team aims to democratize Lombard lending, making it accessible to all, while focusing on mass affluent clients.
• Isembard — Isembard has experience from the military, government, large enterprises, and a successfully exited technology business.

Portfolio highlights

• qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
• Verisian — Verisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs)
• SAPI — SAPI builds credit products for payment companies to facilitate payment flows, engage and retain merchants, and generate new revenue.